Orioles Commit Long-Term to Bradish with Five-Year, $90 Million Extension

The contract includes a precise year-by-year salary progression (10M, 13M, 17M, 22M, 28M) and starts next season, buying out two arbitration years and three potential free-agent seasons for Bradish’s age-30 to age-34 prime.
The extension is framed as a strategic win in Baltimore’s broader plan to draft hitting and buy pitching, aiming to build a sustainable, championship-ready rotation rather than chasing short-term fixes.
Bradish’s health history is a central part of the calculus: he missed major time due to Tommy John surgery in 2024, and 2026 marks his first full season back, posting a 3.61 ERA over 19 starts (with a 6-9 record in that year’s showing).
Bradish was a fourth-round pick by the Angels in 2018 and was part of the 2019 trade that sent Dylan Bundy to the Angels, beginning his Orioles tenure.
In 2023 he finished fourth in the AL Cy Young voting with a 2.83 ERA over 30 starts, a benchmark that the Orioles are betting he can approach again as part of his prime.
The Baltimore Orioles have locked up right-hander Kyle Bradish on a five-year, $90 million extension covering 2027 through 2031, the team announced. The deal buys out two arbitration years and three potential free-agent seasons, keeping Bradish in Baltimore through his age-34 year. Your Conroe News reported Bradish is currently 6-9 with a 3.61 ERA over 19 starts in 2026.
The signing is a clear statement of intent by owner David Rubenstein. Baltimore is betting that Bradish — fresh off Tommy John surgery — can return to the form that made him one of the best pitchers in the American League just three years ago.
The contract's salary structure climbs steadily over five years: $10 million, $13 million, $17 million, $22 million, and $28 million. The back-loaded design rewards Bradish if he stays healthy and pitches deep into his prime. The final year alone — worth $28 million — reflects how much the Orioles value his long-term upside, according to The State.
Bradish won his arbitration case against Baltimore earlier this year, giving him some leverage heading into these talks. The new deal skips the remaining arbitration fights entirely. It also takes him off the free-agent market at what would be his peak earning years.
Bradish missed most of 2024 after undergoing Tommy John surgery, a procedure that repairs a torn elbow ligament. Recovery typically takes 12 to 18 months. The Orioles knew they were signing a pitcher with a recent major injury — and did it anyway. That is a significant vote of confidence.
His 2026 numbers so far ease some concern. A 3.61 ERA over 19 starts is solid, not spectacular. But it shows he can handle a full workload again. Baltimore is clearly willing to bet on the trajectory, not just the current stats.
The Orioles are not paying $90 million for a 3.61 ERA pitcher. They are paying for the pitcher who finished fourth in AL Cy Young voting in 2023 with a 2.83 ERA over 30 starts. That season showed Bradish could be a true ace — durable, consistent, and dominant. Baltimore wants that version back, according to The Olympian.
Bradish has posted a 3.50 ERA across five Orioles seasons in total. That career mark puts him among the better starters in the league over that stretch. The Orioles are betting his age-30 to age-34 seasons will look a lot more like 2023 than 2024.
Bradish originally came to Baltimore in the 2019 trade that sent Dylan Bundy to the Los Angeles Angels. He was a fourth-round pick by the Angels in 2018. Now he is the face of a rotation the Orioles are building through smart acquisitions rather than draft picks alone, according to Fresno Bee.
Owner David Rubenstein has framed the move as part of a long-term vision. The strategy: develop hitters from within the farm system, then spend to lock up top pitching. Signing Bradish at $90 million is the clearest example yet of that plan in action.
Publishers
10
Articles
88
Reach
98